Orexo announces the launch of Abstral® in Japan Uppsala,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Orexo announces the launch of Abstral® in Japan

Uppsala, Sweden – December 12, 2013 – Orexo AB, “Orexo” (OTCQX: ORXOY; NASDAQ OMX Stockholm: ORX) announces today that Kyowa Hakko Kirin Co., Ltd has commenced the launch of Abstral® in Japan. Abstral is a rapidly-disintegrating, sublingual (under the tongue) rapid acting formulation of fentanyl citrate, a well-established opioid, and is indicated for the management of breakthrough pain in cancer patients. Kyowa Hakko Kirin (KHK) licensed the right for Abstral in Japan in 2003 and has completed a dedicated clinical development program for the product in the territory. Abstral will be jointly distributed by KHK and Hisamitsu Pharmaceutical Co., Inc. These companies are well established within the field of cancer pain and have collaborated since 2010. Orexo will receive a single digit royalty on net sales of Abstral in Japan. The manufacturing and marketing approval of Abstral in Japan was received on September 20, 2013 ahead of expectations, and on November 19, 2013 Abstral was listed on the Japanese National Health Insurance Drug Price List. Abstral is the leading fast-acting fentanyl product in Europe, where it achieved full year sales of EUR 41 million (SEK 380 million) in 2012. In the first nine months of 2013, sales exceeded EUR 39 million (SEK 360 million) corresponding to 29 percent growth versus prior year. For further information, please contact: Nikolaj Sørensen, President and CEO Tel: +46-(0)18 780 88 00, E-mail: ir@orexo.com About Abstral® Abstral is a rapidly-disintegrating, sublingual (under the tongue) formulation of fentanyl, a well-established opioid used for the management of episodes of breakthrough pain experienced by cancer patients who are already receiving opioid analgesics for chronic pain. Abstral is approved in the US, EU, Canadian and Japanese markets. About Orexo AB Orexo is an emerging specialty pharma company with commercial operations in the United States and R&D in Sweden developing improved treatments using proprietary drug delivery technology and commercial operations in the United States. The company is commercializing its proprietary product, Zubsolv®, for maintenance treatment of opioid dependence, in the United States. Zubsolv is a novel formulation of buprenorphine and naloxone using Orexo’s extensive knowledge in sublingual technologies. Orexo has a portfolio of two approved and revenue generating products currently marketed under license in the EU and US. Orexo AB, with its headquarters in Sweden, is listed on NASDAQ OMX Stockholm Exchange, under the symbol “ORX”, and its American Depositary Receipts (ADRs) trade on the OTCQX marketplace in the U.S. under the symbol “ORXOY”. The largest shareholders are Novo A/S and HealthCap. For information about Orexo AB, please visit www.orexo.com. About Kyowa Hakko Kirin Kyowa Hakko Kirin is a leading biopharmaceutical company in Japan focusing on its core business area of oncology, nephrology and immunology/allergy. Kyowa Hakko Kirin leverages antibody-related leading-edge technologies to discover and develop innovative new drugs aiming to become a global specialty pharmaceutical company which contributes to the health and well-being of people around the world. For more information, visit www.kyowa-kirin.com . Orexo AB (publ) discloses the information provided herein pursuant to the Financial Instruments Trading Act and/or the Securities Markets Act. The information was submitted for publication at 09:30 am CET on December 12, 2013.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Heineken Hit with €111M Judgment—A Precedent Set

Updated Category News Views 7

A Brew of Legal Consequences for Heineken If this isn't a financial wake-up call for the brewing giant, I don't know what is. In the latest twist of corporate accountability, the Amsterdam District Court has ordered Heineken and its Greek subsidiary, Athenian Brewery, to cough up a whopping €111 million. And we're not just talking pocket change—this ruling speaks...

Continue Reading
Station Casinos Secures $500M Loan Amid Economic Challenges

Updated Category News Views 4

Is Leveraging Debt the Right Move for Station Casinos? Las Vegas just can't stay out of the news, can it? This time, it's all about Station Casinos and their big move to rustle up $500 million in cold, hard cash through an incremental Term B Loan. A move like this ain't exactly playin' it safe, but let's dive deeper into why they're chasing these greenbacks. What's the...

Continue Reading
Side Bolsters Art Division with Roboto Acquisition

Updated Category News Views 7

Breaking Into China's Game Art Market The gaming industry's latest buzz centers around Side's acquisition of Roboto Entertainment, a boutique art studio known for crafting immersive game environments. This isn't just another headline grab—this move puts Side smack dab in the heart of China's burgeoning game market with a fresh Chengdu base. Expansion With Strategic...

Continue Reading
Eightpoint Backs Community Shelter with Vital Aid

Updated Category News Views 4

Eightpoint Technologies Steps Up for a Crucial Cause Kicking in when it counts, Eightpoint Technologies has done something that might not turn stock market heads but speaks volumes about corporate responsibility. They're ponying up for a year's worth of groceries for the Cayman Islands Crisis Centre (CICC) starting November 1, 2026. We're talking real relief for women and...

Continue Reading
Innventure Investors Alert: Securities Investigation Looms

Updated Category News Views 3

Innventure's Murky Waters Just when you think you've seen it all, stuff like this reminds you nothing's safe in the market. The law folks at Stranch, Jennings & Garvey, PLLC are sniffing around Innventure, Inc. (NASDAQ: INV) like bloodhounds to see if there's been some hoodwinking going on. We're talking questions about funny business with a data center deal between...

Continue Reading
Phoenix Reveals Cost-Saving Hacks for Transfer Students

Updated Category News Views 7

Making College Cost Manageable Okay, let's get real about college costs. Tuition fees got folks holding their breath tighter than a bull in a bear market. University of Phoenix ain't turning a blind eye—during National Transfer Student Week, they're shouting from the rooftops about pocket-friendly ways to snag that degree without selling your soul or flipping another...

Continue Reading
Getac’s B360X Pro: Pushing AI to New Extremes

Updated Category News Views 1

A Technological Game-Changer from Getac Every so often, a piece of tech arrives that sends ripples through the sector. Getac’s next-gen B360X and B360X Pro are exactly that. These machines aren’t your average laptops—they’re built to butcher bad conditions while harnessing some mean AI power. Trust me, these aren't merely updates; they’ve got some serious DNA...

Continue Reading
Sunlife Partners With Rippling to Streamline Benefits

Updated Category News Views 5

Sunlife Enters the Tech Game It ain't your granddaddy's insurance world no more. Sunlife U.S. is hopping on the tech bandwagon, joining Rippling's Preferred Carrier Program to make employee benefits slicker and faster. This isn't just about insurance paperwork; it's about reshaping how businesses handle their payroll, IT, and HR under one digital roof. Why it Matters for...

Continue Reading
Rotoplas Q3 2026: Mixed Results Amid Challenges

Updated Category News Views 4

An Intriguing Quarter for Rotoplas With third-quarter results rolling in from Grupo Rotoplas S.A.B. de C.V., let's dig into the numbers and see what shook out. These guys topped $2.9 billion in net sales, cruising at a 9.6% increase compared to the same quarter last year. Sure, the headlines might look rosy, but peel back a layer, and you'll see the complexities that...

Continue Reading
Ecology Auto Parts Faces Class Action for Labor Code Violations

Updated Category News Views 2

Legal Battle Unfolds: Employees Take a Stand Step right up, folks, and get a load of the latest legal rumble pitting employees against the big machine of Ecology Auto Parts, Inc. Operating out of California, these auto-wrecking giants are now staring down the barrel of a class action lawsuit alleging they're skimping on labor law essentials. The lawsuit, which the folks...

Continue Reading

Top 5 Most Recently Viewed Articles

Celmatix Unveils Innovative JNK Inhibitor for Women's Health

Updated Category News Views 354

Celmatix Therapeutics Announces New Drug Program Celmatix Therapeutics, a biotechnology company dedicated to women's health, has recently launched an ambitious drug program focusing on a novel Jun-N-terminal kinase (JNK) inhibitor. This innovative therapeutic drug candidate is designed to effectively target pain and inflammation associated with various female health...

Continue Reading
Accelera's 100 MW Electrolyzer Powers Green Hydrogen Vision

Updated Category News Views 226

Accelera's Role in Green Hydrogen Production Accelera by Cummins, recognized for its commitment to zero-emissions solutions, is set to revolutionize the green hydrogen landscape with a groundbreaking 100-megawatt (MW) proton exchange membrane (PEM) electrolyzer system. This development, aimed at enhancing renewable energy projects, will play an instrumental role in bp's...

Continue Reading
Curinos Amplero Achieves Gold Recognition at MarCom Awards

Updated Category News Views 182

Curinos Amplero's Award-Winning AI Solution Recently, Curinos, a leading data intelligence firm in the financial sector, achieved prestigious recognition at the MarCom Awards for its innovative AI-powered platform, Amplero Personalization Optimizer. This platform, celebrated for its generative AI capabilities, played a vital role in the Private Wealth Cross-Sell Campaign...

Continue Reading
Florida Housing Market Trends: Sales Surge in 2025

Updated Category News Views 273

Florida Housing Market Trends Overview As we dive into the current state of Florida's housing market, it's clear that exciting developments are taking place. In September, the sales of existing single-family homes experienced a robust increase of 13.6% compared to the previous year. Similarly, the sales of existing condo-townhouse units rose by 8% within the same...

Continue Reading
Oakio Achieves Excellence at Batimat 2024 Showcase

Updated Category News Views 181

Oakio Concludes Successful Participation at Batimat 2024 Oakio has successfully concluded its participation in Batimat 2024, a notable event held recently. This exhibition provided an excellent platform for showcasing a wide array of innovative Wood-Plastic Composite (WPC) solutions while connecting with industry professionals from around the world. Highlighting...

Continue Reading